Why Is Penny Stock Coeptis Therapeutics Gaining Today?

Coeptis Therapeutics Holdings, Inc. COEP shares traded higher on Thursday after the company announced the completion of its acquisition of the NexGenAI Affiliates Network platform and the launch of Coeptis Technologies.

This new division is designed to diversify the company’s growth potential, specifically in highly regulated industries like biotech, pharmaceuticals, and multi-level marketing.

The NexGenAI Affiliates Network platform, developed by NexGenAI Solutions Group, is an AI-powered marketing software and robotic process automation (RPA) solution.

This tool helps marketers process large volumes of data, optimize campaigns, improve customer engagement, and streamline operations—key factors for success in the competitive and regulated sectors Coeptis serves.

Also Read: SEALSQ Launches SEALQUANTUM.com Lab To Help Businesses Transition To Quantum-Safe Encryption

Dave Mehalick, President and CEO of Coeptis, highlighted that integrating these AI-driven tools will be crucial for optimizing marketing strategies and driving measurable results in industries where competition and regulatory challenges are intense.

Anshuman Dash, Lead Advisor behind the NexGenAI platform, emphasized that this acquisition aligns with Coeptis’ mission to revolutionize marketing and operational efficiency in the biopharmaceutical sector.

By leveraging advanced AI and RPA technologies, Coeptis aims to enhance its service offerings and provide innovative solutions to overcome marketing challenges in the biotech, pharma, and MLM sectors, setting the stage for future growth.

Price Action: COEP shares are trading higher by 45.8% to $0.2070 at last check Thursday.

Read Next:

• Tech Bull Predicts 26% Upside For Apple Stock, Sees ‘Golden Era Of Growth’ For Cupertino Due To Multi-Year AI-Driven iPhone Upgrade Cycle

Photo via Shutterstock.